CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Matthew Baker, Colin Walsh |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 14.50p |
Change Today | -0.50p |
% Change | -3.33 % |
52 Week High | 17.50p |
52 Week Low | 3.25p |
Volume | 555,010 |
Shares Issued | 113.66m |
Market Cap | £16.48m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:30 | 3,325 @ 14.75p |
11:23 | 9,954 @ 14.10p |
11:19 | 725 @ 14.10p |
11:08 | 14,260 @ 14.10p |
10:02 | 56,366 @ 14.78p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research